32 lines
2.0 KiB
Markdown
32 lines
2.0 KiB
Markdown
# Too Good to be True
|
||
|
||
**Category:** Database
|
||
|
||
**Points:** 310
|
||
|
||
## Description
|
||
|
||
\<iframe src="" style="background-image: url('https://deadface.sfo3.cdn.digitaloceanspaces.com/2026/img/wayfinder/too_good_to_be_true.png');background-size:cover;background-position:center center;background-origin:content-box;background-repeat:no-repeat;background-color:rgba(40, 40, 40,0);min-height:80px;height:130px;width:100%;padding:10px;border:none" title="Thumbnail">\</iframe>
|
||
\<sup>Created By: \<code>@syyntax\</code>\</sup>
|
||
\<style>
|
||
.tiny-text {
|
||
font-size: 6px;
|
||
color: #1a1a1a;
|
||
}
|
||
\</style>
|
||
\<span class="tiny-text">flag{a37251146d9b63b7}\</span>
|
||
|
||
|
||
The post-lock edit wasn't the only fabrication in the Veltrexa trial. One subject's recorded efficacy improvement is a statistical impossibility — it sits more than three standard deviations above the study-wide mean for the primary endpoint, a telltale sign that a number was invented rather than measured. Identify that outlier subject and report their subject code.
|
||
|
||
Use the provided MySQL shell.
|
||
|
||
Submit the subject code as `deadface{subject_code}`. Example: `deadface{ABCD-0101}`.
|
||
|
||
[Access Database](https://aurora.dctf.io)
|
||
|
||
## Services
|
||
|
||
- [https://deadface.sfo3.cdn.digitaloceanspaces.com](https://deadface.sfo3.cdn.digitaloceanspaces.com)
|
||
- [https://aurora.dctf.io)](https://aurora.dctf.io))
|